Pathstone Family Office’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.07M | Buy |
10,404
+5,651
| +119% | +$584K | 0.01% | 679 |
|
|
2023
Q2 | $610K | Sell |
4,753
-870
| -15% | -$112K | 0.01% | 664 |
|
|
2023
Q1 | $912K | Sell |
5,623
-14,039
| -71% | -$2.28M | 0.01% | 473 |
|
|
2022
Q4 | $2.72M | Buy |
19,662
+7,317
| +59% | +$1.01M | 0.02% | 417 |
|
|
2022
Q3 | $1.46M | Buy |
12,345
+8,546
| +225% | +$1.01M | 0.01% | 553 |
|
|
2022
Q2 | $543K | Buy |
3,799
+963
| +34% | +$138K | 0.01% | 543 |
|
|
2022
Q1 | $489K | Buy |
2,836
+651
| +30% | +$112K | 0.01% | 559 |
|
|
2021
Q4 | $554K | Sell |
2,185
-1,760
| -45% | -$446K | 0.01% | 521 |
|
|
2021
Q3 | $1.52M | Buy |
3,945
+862
| +28% | +$332K | 0.04% | 207 |
|
|
2021
Q2 | $725K | Sell |
3,083
-2,317
| -43% | -$545K | 0.02% | 361 |
|
|
2021
Q1 | $707K | Buy |
5,400
+5,180
| +2,355% | +$678K | 0.02% | 276 |
|
|
2020
Q4 | $23K | Buy |
220
+120
| +120% | +$12.5K | ﹤0.01% | 655 |
|
|
2020
Q3 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 638 |
|
|
2020
Q2 | – | Sell |
-300
| Closed | -$9K | – | 882 |
|
|
2020
Q1 | $9K | Buy |
+300
| New | +$9K | ﹤0.01% | 548 |
|